Ballentine Partners’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-12,353
Closed -$199K – 1035
2025
Q4
$199K Sell
12,353
-907
-7% -$16K ﹤0.01% 930
2025
Q3
$254K Sell
13,260
-596
-4% -$10.7K ﹤0.01% 805
2025
Q2
$243K Sell
13,856
-4,138
-23% -$73.5K ﹤0.01% 789
2025
Q1
$364K Buy
17,994
+1,206
+7% +$24.4K 0.01% 555
2024
Q4
$340K Buy
16,788
+135
+0.8% +$2.92K 0.01% 554
2024
Q3
$381K Buy
16,653
+1,577
+10% +$34K 0.01% 503
2024
Q2
$295K Buy
15,076
+898
+6% +$17.1K 0.01% 567
2024
Q1
$266K Buy
14,178
+1,163
+9% +$21.1K 0.01% 582
2023
Q4
$258K Buy
+13,015
New +$229K 0.01% 552
2023
Q3
– Sell
-22,196
Closed -$446K – 616
2023
Q2
$446K Buy
+22,196
New +$461K 0.01% 340
2023
Q1
– Sell
-8,243
Closed -$207K – 577
2022
Q4
$207K Sell
8,243
-1,462
-15% -$35.5K 0.01% 455
2022
Q3
$223K Buy
9,705
+1,446
+18% +$38.2K 0.01% 413
2022
Q2
$215K Sell
8,259
-1,399
-14% -$42.4K 0.01% 389
2022
Q1
$332K Sell
9,658
-3,420
-26% -$115K 0.01% 332
2021
Q4
$471K Buy
13,078
+4,302
+49% +$148K 0.01% 277
2021
Q3
$294K Buy
8,776
+318
+4% +$11.3K 0.01% 318
2021
Q2
$281K Buy
8,458
+256
+3% +$8.59K 0.01% 333
2021
Q1
$261K Sell
8,202
-723
-8% -$22K 0.01% 322
2020
Q4
$270K Sell
8,925
-96
-1% -$2.79K 0.01% 307
2020
Q3
$245K Buy
9,021
+214
+2% +$5.86K 0.01% 328
2020
Q2
$243K Sell
8,807
-1,138
-11% -$29.1K 0.01% 315
2020
Q1
$237K Sell
9,945
-630
-6% -$20.5K 0.01% 290
2019
Q4
$365K Hold
10,575
– – 0.02% 269
2019
Q3
$377K Buy
10,575
+521
+5% +$17.6K 0.02% 248
2019
Q2
$322K Buy
+10,054
New +$313K 0.02% 279

Other funds holding DOC

Ballentine Partners's DOC Position: Q1 2026 in Review

Ballentine Partners sold out of Healthpeak Properties (DOC) in Q1 2026, closing a stake of 12,353 shares — an estimated $199K sold.

Ballentine Partners first reported a position in DOC in Q2 2019 and held it in 25 quarters. The position peaked at $471K in Q4 2021. 761 funds tracked by Wall St. Rank hold DOC as of Q1 2026.

  • Ballentine Partners reported no remaining Healthpeak Properties position as of Q1 2026 after selling out during the quarter.
  • Ballentine Partners sold 12,353 Healthpeak Properties shares in Q1 2026, an estimated $199K.
  • Ballentine Partners first reported a position in Healthpeak Properties in Q2 2019 and held it in 25 quarters.
  • Ballentine Partners's Healthpeak Properties position peaked at $471K in Q4 2021.
  • 761 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2026.

Based on Ballentine Partners's 13F filing for Q1 2026, filed 14 May 2026.